NO20062142L - Farmasoytisk doseringsform med forlenget frigjoring - Google Patents

Farmasoytisk doseringsform med forlenget frigjoring

Info

Publication number
NO20062142L
NO20062142L NO20062142A NO20062142A NO20062142L NO 20062142 L NO20062142 L NO 20062142L NO 20062142 A NO20062142 A NO 20062142A NO 20062142 A NO20062142 A NO 20062142A NO 20062142 L NO20062142 L NO 20062142L
Authority
NO
Norway
Prior art keywords
venlafaxine
dosage forms
release pharmaceutical
pharmaceutical dosage
dosage form
Prior art date
Application number
NO20062142A
Other languages
English (en)
Norwegian (no)
Inventor
James Andrew Provost
Nicholas Heaton
Angela Potts
Ian Armstrong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34354596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062142(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20062142L publication Critical patent/NO20062142L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20062142A 2003-10-13 2006-05-12 Farmasoytisk doseringsform med forlenget frigjoring NO20062142L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03256438A EP1523979A1 (en) 2003-10-13 2003-10-13 Extended release pharmaceutical dosage form
PCT/EP2004/011339 WO2005039527A2 (en) 2003-10-13 2004-10-11 Extended release pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
NO20062142L true NO20062142L (no) 2006-07-06

Family

ID=34354596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062142A NO20062142L (no) 2003-10-13 2006-05-12 Farmasoytisk doseringsform med forlenget frigjoring

Country Status (14)

Country Link
US (1) US20050129762A1 (es)
EP (2) EP1523979A1 (es)
KR (1) KR20060108675A (es)
CN (1) CN1889935A (es)
AR (1) AR046102A1 (es)
AU (1) AU2004283436A1 (es)
CA (1) CA2546199A1 (es)
CO (1) CO5690532A2 (es)
CR (1) CR8403A (es)
EC (1) ECSP066566A (es)
NO (1) NO20062142L (es)
PE (1) PE20050439A1 (es)
TW (1) TW200518788A (es)
WO (1) WO2005039527A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
RU2401125C2 (ru) * 2004-12-27 2010-10-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ стабилизации лекарственного средства против деменции
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
JP5290198B2 (ja) * 2006-12-20 2013-09-18 ミラン ファーマシューティカルズ ユーエルシー ホットメルト顆粒化潤滑剤を含んでなる医薬組成物
EP2139466B1 (en) 2007-03-22 2019-10-23 Neurocentria, Inc. Magnesium compositions and uses thereof
US20080249178A1 (en) 2007-03-22 2008-10-09 Guosong Liu Magnesium compositions and uses thereof for increasing lifespan
US8377473B2 (en) 2009-07-01 2013-02-19 Magceutics, Inc. Slow release magnesium composition and uses thereof
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (es) * 1956-03-27
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6033686A (en) * 1998-10-30 2000-03-07 Pharma Pass Llc Controlled release tablet of bupropion hydrochloride
US20030059466A1 (en) * 2001-09-14 2003-03-27 Pawan Seth Delayed release tablet of venlafaxin
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
AR039166A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Composiciones de venlafaxina base
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
DE60331236D1 (de) * 2003-07-24 2010-03-25 Eswaran Krishnan Iyer Orale zusammensetzungen zur behandlung von diabetes

Also Published As

Publication number Publication date
CR8403A (es) 2006-10-26
AR046102A1 (es) 2005-11-23
CO5690532A2 (es) 2006-10-31
TW200518788A (en) 2005-06-16
US20050129762A1 (en) 2005-06-16
PE20050439A1 (es) 2005-08-03
EP1523979A1 (en) 2005-04-20
CN1889935A (zh) 2007-01-03
AU2004283436A1 (en) 2005-05-06
WO2005039527A2 (en) 2005-05-06
KR20060108675A (ko) 2006-10-18
WO2005039527A3 (en) 2006-04-06
ECSP066566A (es) 2006-10-17
EP1675575A2 (en) 2006-07-05
CA2546199A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
NO20062142L (no) Farmasoytisk doseringsform med forlenget frigjoring
CY1121350T1 (el) Απο του στοματος φαρμακοτεχνικες μορφες αναλογων κυτιδινης και μεθοδοι χρησης αυτων
CY1121877T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
CY1122575T1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
BRPI0605214A (pt) composição farmacêutica orodispersável para administração por via mucosa oral ou sublingual de agomelatina
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
CY1106741T1 (el) Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης
CY1122416T1 (el) Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
NO20082547L (no) Orale formuleringer omfattende tigecycline
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
WO2006050472A3 (en) Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
NO20062143L (no) Tablettformuleringer av venlafaxin med forlenget frigjoring
WO2019194773A3 (en) The combination comprising linagliptin and metformin
BR0312522A (pt) Método para a preparação de trombina inativada por vìrus, trombina, formulação farmacêutica, e, kit farmacêutico
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
WO2006050471A3 (en) Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
NO20065013L (no) Dosering med kontrollert frigivelse for GABA-reseptoragonist
BRPI0512393A (pt) vacinação de jaritataca e/ou mangusto contra raiva
WO2007048080A3 (en) Stable pharmaceutical formulations containing escitalopram and bupropion
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
HUP0401161A2 (hu) Lerkanidipin-hidroklorid szolvátjai és lerkanidipin-hidroklorid új kristályos formái, eljárás előállításukra és a kristályos formákat tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application